BAXTER INTERNATIONAL INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
BAXTER INTERNATIONAL INC. (BAX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$6.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2022-02-23
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-12-31 was $0.00.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-09-30 was -$1.00M, a 200.00% decline year-over-year.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-06-30 was -$5.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2021-03-31 was $0.00.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2021 was -$6.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2020 was -$2.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2017 was $1.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$1.00M derived: sum of 2 quarters · filed 2022-02-23 | -$6.00M derived: sum of 3 quarters · filed 2022-02-23 | -$6.00M 10-K · filed 2022-02-23 | |
| 2021-09-30 | -$1.00M 10-Q · filed 2021-10-28 | -$6.00M derived: sum of 2 quarters · filed 2021-10-28 | -$6.00M 10-Q · filed 2021-10-28 | -$6.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2021-06-30 | -$5.00M 10-Q · filed 2021-07-29 | -$5.00M 10-Q · filed 2021-07-29 | -$5.00M derived: sum of 3 quarters · filed 2022-02-23 | -$4.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-23 | $1.00M derived: sum of 3 quarters · filed 2022-02-23 | $1.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.00M derived: sum of 2 quarters · filed 2022-02-23 | $1.00M derived: sum of 3 quarters · filed 2022-02-23 | -$2.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $1.00M 10-Q · filed 2021-10-28 | $1.00M derived: sum of 2 quarters · filed 2021-10-28 | -$2.00M 10-Q · filed 2021-10-28 | -$2.00M derived: sum of 4 quarters · filed 2021-10-28 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | -$3.00M 10-Q · filed 2021-07-29 | -$3.00M derived: sum of 3 quarters · filed 2021-07-29 | -$3.00M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | -$3.00M 10-Q · filed 2021-04-29 | -$3.00M derived: sum of 2 quarters · filed 2021-04-29 | -$3.00M derived: sum of 3 quarters · filed 2021-04-29 | -$7.00M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2021-04-29 | -$4.00M derived: sum of 3 quarters · filed 2021-04-29 | -$4.00M 8-K · filed 2021-04-29 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 | -$4.00M derived: sum of 2 quarters · filed 2020-10-29 | -$4.00M 10-Q · filed 2020-10-29 | -$4.00M derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | -$4.00M 10-Q · filed 2020-07-30 | -$4.00M 10-Q · filed 2020-07-30 | -$4.00M derived: sum of 3 quarters · filed 2020-07-30 | -$4.00M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2020-04-30 | $0.00 derived: sum of 3 quarters · filed 2020-04-30 | $0.00 derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $0.00 derived: sum of 2 quarters · filed 2020-03-17 | $0.00 derived: sum of 3 quarters · filed 2020-03-17 | $0.00 10-K · filed 2020-03-17 | |
| 2018-09-30 | $0.00 10-Q · filed 2020-03-17 | $0.00 derived: sum of 2 quarters · filed 2020-03-17 | $0.00 10-Q · filed 2020-03-17 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-30 | $0.00 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $1.00M 10-K · filed 2019-02-21 | ||||
| 2015-12-31 | $22.00M 10-K · filed 2017-02-23 | ||||
| 2014-12-31 | -$41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$42.00M derived: sum of 2 quarters · filed 2016-02-26 | $1.00M 10-K · filed 2016-02-26 | $122.00M 10-K · filed 2015-02-26 | |
| 2014-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $42.00M 10-Q · filed 2014-10-29 | |||
| 2014-06-30 | $43.00M 10-Q · filed 2014-07-30 | ||||
| 2013-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$15.00M derived: sum of 2 quarters · filed 2015-02-26 | -$17.00M 10-K · filed 2015-02-26 | ||
| 2013-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$9.00M 10-Q · filed 2013-10-30 | |||
| 2013-06-30 | -$2.00M 10-Q · filed 2013-07-31 | ||||
| 2012-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$8.00M derived: sum of 2 quarters · filed 2014-02-21 | -$47.00M derived: sum of 3 quarters · filed 2014-02-21 | -$108.00M 10-K · filed 2014-02-21 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$39.00M derived: sum of 2 quarters · filed 2012-11-01 | -$100.00M 10-Q · filed 2012-11-01 | ||
| 2012-06-30 | -$39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$100.00M 10-Q · filed 2012-08-02 | |||
| 2012-03-31 | -$61.00M 10-Q · filed 2012-05-03 | ||||
| 2011-12-31 | $7.00M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |